[Form 4] Transcat Inc Insider Trading Activity

Rhea-AI Filing Summary

Christopher P. Gillette, a director of Transcat Inc. (TRNS), reported changes in his beneficial ownership on Form 4. The filing shows 704 shares were acquired on 09/11/2025 through the vesting of restricted stock units (RSUs) and are reported with a $0 per-share conversion value. The document also discloses an earlier RSU grant of 1,587 RSUs dated 09/10/2025 that convert one-for-one to common stock and generally vest on 09/10/2026. In addition, Mr. Gillette holds a stock option covering 10,000 shares with an exercise price of $109.55 and pro rata vesting over five years. The filing was signed by an attorney-in-fact on behalf of Mr. Gillette on 09/11/2025.

Positive

• 704 shares were acquired through RSU vesting on 09/11/2025, increasing director alignment with shareholders
• A new RSU grant of 1,587 RSUs (convert one-for-one) provides multi-year retention through 09/10/2026
• Outstanding stock option for 10,000 shares with a fixed exercise price of $109.55 aligns long-term incentives

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Director received vested RSUs and holds a long-dated option, indicating routine executive compensation alignment.

The Form 4 discloses standard equity compensation events: conversion of RSUs into 704 shares upon vesting and a separate grant of RSUs that vest next year. The 10,000-share option with a $109.55 exercise price vests pro rata over five years, consistent with multi-year retention incentives. These transactions are routine, disclosed under Rule 16 reporting, and do not indicate unusual insider trading or extraordinary corporate actions.

Securities Analyst

TL;DR: Modest equity vesting and an outstanding option are disclosed; impact on share count and ownership is limited.

The conversion of RSUs into 704 shares increases Mr. Gillette's direct holdings by that amount. The additional 1,587 RSUs remain subject to typical vesting conditions through 09/10/2026. The 10,000-share option represents potential future dilution if exercised, subject to vesting schedule and exercise price of $109.55. None of the reported items alone appears materially dilutive or likely to change control stakes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gillette Christopher P.

(Last) (First) (Middle)

C/O TRANSCAT, INC.

35 VANTAGE POINT DRIVE

(Street)

ROCHESTER NY 14624

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSCAT INC [ TRNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.50 par value	09/11/2025		M		704	A	$0(1)	704	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	09/10/2025		A		1,587		(2)	(2)	Common Stock, $.50 par value	1,587	$0	1,587	D
Restricted Stock Units	$0(1)	09/11/2025		M			704	(3)	(3)	Common Stock, $.50 par value	704	$0	0	D
Stock Option (Right to Buy)	$109.55							(4)	09/06/2033	Common Stock, $.50 par value	10,000		10,000	D

Explanation of Responses:

1. These restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

2. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 10, 2026.

3. These RSUs vested on September 11, 2025.

4. This option vests and becomes exercisable pro rata with respect to one-fifth of the shares subject to the option on the first, second, third, fourth and fifth anniversaries of the date of grant, except as otherwise provided in the award agreement.

	/s/ Kristina L. Johnston, Attorney-in-Fact for Christopher P. Gillette	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Christopher P. Gillette report on Form 4 for TRNS?

The filing reports the vesting of 704 RSUs on 09/11/2025, a grant of 1,587 RSUs dated 09/10/2025 that vest on 09/10/2026, and an outstanding 10,000-share option with a $109.55 exercise price.

How many shares did Gillette beneficially own after the reported transaction?

The Form 4 reports 704 shares acquired on 09/11/2025; following that transaction, the reported beneficial ownership associated with the vested RSUs is 704 shares for that line item.

What are the vesting details for the RSUs disclosed for TRNS director Gillette?

The 1,587 RSUs granted 09/10/2025 convert one-for-one to common stock and generally vest on 09/10/2026. The 704 RSUs vested on 09/11/2025 per the filing.

What are the terms of the stock option disclosed on the Form 4?

The filing shows a stock option covering 10,000 shares with an exercise price of $109.55. The option vests pro rata over five years (one-fifth on each anniversary of the grant date) as stated in the explanation.

Who signed the Form 4 filing for Christopher P. Gillette?

The Form 4 was signed on behalf of Christopher P. Gillette by Kristina L. Johnston, Attorney-in-Fact on 09/11/2025.